Ultragenyx (RARE) CFO trims stake with 4,683-share open-market sale
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Ultragenyx Pharmaceutical Inc.’s Chief Financial Officer Howard Horn reported an open-market sale of 4,683 shares of common stock at $24.90 per share. After this transaction, he directly owns 110,342 shares, which the disclosure notes include shares underlying RSUs that are subject to vesting conditions.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 4,683 shares ($116,607)
Net Sell
1 txn
Insider
Horn Howard
Role
Chief Financial Officer
Sold
4,683 shs ($117K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 4,683 | $24.90 | $117K |
Holdings After Transaction:
Common Stock — 110,342 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Shares sold: 4,683 shares
Sale price: $24.90 per share
Post-transaction holdings: 110,342 shares
3 metrics
Shares sold
4,683 shares
Common stock sold in open-market transaction
Sale price
$24.90 per share
Price for the 4,683 common shares sold
Post-transaction holdings
110,342 shares
Directly owned after sale, including RSU underlying shares
Key Terms
open-market sale, RSUs, vesting conditions, non-derivative
4 terms
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
RSUs financial
"shares of common stock underlying RSUs granted to the Reporting Person"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
vesting conditions financial
"RSUs granted to the Reporting Person, which are subject to certain vesting conditions"
Vesting conditions are the rules that determine when someone earning company stock or stock options actually gains the right to keep or sell them, typically based on staying with the company for a set time or meeting performance targets. Think of it like keys that unlock gradually — some unlock by calendar date, others only after agreed milestones. Investors care because vesting shapes management incentives, the timing of share sales, and the number of shares that can enter the market, which can affect a company's valuation and ownership mix.
non-derivative financial
""transaction_type": "non-derivative""
FAQ
What insider transaction did Ultragenyx (RARE) disclose in this Form 4?
Ultragenyx disclosed that Chief Financial Officer Howard Horn completed an open-market sale of company common stock. The filing reports a single transaction in which he sold 4,683 shares, providing details on the sale price and his direct share ownership after the transaction.
Do the CFO’s reported Ultragenyx (RARE) holdings include RSUs?
Yes. A footnote explains that the reported holdings include previously reported shares underlying RSUs granted to Howard Horn. These restricted stock units are subject to vesting conditions, meaning some of the reported shares represent awards that vest over time rather than already fully unrestricted stock.